Clene Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
CLNN Nasdaq 2836 clene.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Clene Inc.

Clene Provides Regulatory Update Following Constructive FDA Type-C Meeting on Neurofilament Biomarker Analysis Plan and Confirms Two Additional FDA Meetings - Jun 30th, 2025 6:00 am
Q2 Virtual Investor Summit: Presentations Available Now - Jun 25th, 2025 9:15 am
When Will Clene Inc. (NASDAQ:CLNN) Breakeven? - Jun 24th, 2025 5:26 am
Clene Inc. Chief Executive Officer Rob Etherington to Present at the Investor Summit Virtual on June 10, 2025 - Jun 9th, 2025 7:00 am
Presenting on Emerging Growth Conference 82 Day 1 on May 21; Register to live stream - May 20th, 2025 5:00 am
Clene Reports First Quarter 2025 Financial Results and Recent Operating Highlights - May 7th, 2025 6:00 am
Clene Inc. Announces Participation in the D. Boral Capital Inaugural Global Conference - May 7th, 2025 6:00 am
Presenting on Emerging Growth Conference 81 Day 2 on April 17; Register to live stream - Apr 16th, 2025 5:00 am
Clene to Present at the Emerging Growth Conference - Apr 14th, 2025 6:30 am
Clene Presents Evidence of Remyelination and Neuronal Repair With CNM-Au8® Treatment At the American Academy of Neurology Late-Breaking Science Session - Apr 8th, 2025 6:00 am
Clene to Present at the Jones Healthcare and Technology Innovation Conference - Apr 1st, 2025 6:30 am
Clene to Participate in Jones Las Vegas Technology and Innovation Conference on April 8-9, 2025 - Mar 25th, 2025 6:30 am
Clene Reports Full Year 2024 Financial Results and Recent Operating Highlights - Mar 24th, 2025 6:00 am
Bullish Clene Insiders Loaded Up On US$583.4k Of Stock - Mar 20th, 2025 6:08 am
Q1 Virtual Investor Summit: On-Demand Presentations Now Live - Mar 18th, 2025 1:30 pm
Clene Demonstrates Strengthened ALS Survival Benefit with CNM-Au8® Treatment - Mar 12th, 2025 6:00 am
Clene to Present at the 37TH Annual Roth Conference - Mar 6th, 2025 6:30 am
Clene Inc. Rob Etherington, CEO, and Morgan Brown, CFO, to Present at the Investor Summit Virtual on March 11 - Feb 27th, 2025 7:15 am
Clene and APST Enter Into an Agreement to Support FDA’s Recommendation for Long-Term NfL Biomarker Analyses of CNM-Au8®’s Impact on NfL Reduction - Feb 25th, 2025 6:00 am
Is Clene Inc. (CLNN) the Best Nanotech Penny Stock to Invest In? - Feb 14th, 2025 9:29 am